Home > Pharmaceutical Strategy for Europe. Communication from the Commission to the European Parliament, The Council, The European Economic and Social Committee and the Committee of the Regions.

European Commission. (2020) Pharmaceutical Strategy for Europe. Communication from the Commission to the European Parliament, The Council, The European Economic and Social Committee and the Committee of the Regions. Brussels: European Commission. COM(2020) 761 final.

[img]
Preview
PDF (Pharmaceutical Strategy for Europe)
733kB

External website: https://ec.europa.eu/health/medicinal-products/pha...


Good health is central to wellbeing and depends on a multitude of factors including healthy lifestyles and fair and equitable access to healthcare, a central pillar of the European way of life. Healthcare in turn requires safe, effective and affordable medicines. Great progress has been made on human health in the European Union in recent years,  with average life expectancy at birth in the EU having increased by 3.3 years since 2002. New medicines, vaccines and treatments have helped to tackle some of the leading causes of disease and life threatening illnesses.

Item Type
Report
Publication Type
Irish-related, International, Report
Drug Type
Prescription/Over the counter
Date
November 2020
Identification #
COM(2020) 761 final
Pages
25 p.
Publisher
European Commission
Corporate Creators
European Commission
Place of Publication
Brussels
EndNote

Repository Staff Only: item control page